Dexamethasone Sodium Phosphate Preparation
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Herceptin (Trastuzumab) Market Research Report 2024
1 Herceptin (Trastuzumab) Market Overview
1.1 Product Overview and Scope of Herceptin (Trastuzumab)
1.2 Herceptin (Trastuzumab) Segment by Type
1.2.1 Global Herceptin (Trastuzumab) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Breast Cancer
1.2.3 Stomach Cancer
1.2.4 Others
1.3 Herceptin (Trastuzumab) Segment by Application
1.3.1 Global Herceptin (Trastuzumab) Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Global Herceptin (Trastuzumab) Market Size Estimates and Forecasts
1.4.1 Global Herceptin (Trastuzumab) Revenue 2017-2028
1.4.2 Global Herceptin (Trastuzumab) Sales 2017-2028
1.4.3 Herceptin (Trastuzumab) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Herceptin (Trastuzumab) Market Competition by Manufacturers
2.1 Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Herceptin (Trastuzumab) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Herceptin (Trastuzumab) Manufacturing Sites, Area Served, Product Type
2.5 Herceptin (Trastuzumab) Market Competitive Situation and Trends
2.5.1 Herceptin (Trastuzumab) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Herceptin (Trastuzumab) Players Market Share by Revenue
2.5.3 Global Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Herceptin (Trastuzumab) Retrospective Market Scenario by Region
3.1 Global Herceptin (Trastuzumab) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Herceptin (Trastuzumab) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Herceptin (Trastuzumab) Market Facts & Figures by Country
3.3.1 North America Herceptin (Trastuzumab) Sales by Country
3.3.2 North America Herceptin (Trastuzumab) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Herceptin (Trastuzumab) Market Facts & Figures by Country
3.4.1 Europe Herceptin (Trastuzumab) Sales by Country
3.4.2 Europe Herceptin (Trastuzumab) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Herceptin (Trastuzumab) Market Facts & Figures by Region
3.5.1 Asia Pacific Herceptin (Trastuzumab) Sales by Region
3.5.2 Asia Pacific Herceptin (Trastuzumab) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Herceptin (Trastuzumab) Market Facts & Figures by Country
3.6.1 Latin America Herceptin (Trastuzumab) Sales by Country
3.6.2 Latin America Herceptin (Trastuzumab) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Herceptin (Trastuzumab) Market Facts & Figures by Country
3.7.1 Middle East and Africa Herceptin (Trastuzumab) Sales by Country
3.7.2 Middle East and Africa Herceptin (Trastuzumab) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Herceptin (Trastuzumab) Historic Market Analysis by Type
4.1 Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
4.2 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2022)
4.3 Global Herceptin (Trastuzumab) Price by Type (2017-2022)
5 Global Herceptin (Trastuzumab) Historic Market Analysis by Application
5.1 Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
5.2 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2022)
5.3 Global Herceptin (Trastuzumab) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Corporation Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Genentech
6.2.1 Genentech Corporation Information
6.2.2 Genentech Description and Business Overview
6.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Genentech Herceptin (Trastuzumab) Product Portfolio
6.2.5 Genentech Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis AG Herceptin (Trastuzumab) Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Herceptin (Trastuzumab) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Abnova Corporation
6.5.1 Abnova Corporation Corporation Information
6.5.2 Abnova Corporation Description and Business Overview
6.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Abnova Corporation Herceptin (Trastuzumab) Product Portfolio
6.5.5 Abnova Corporation Recent Developments/Updates
6.6 InvivoGen
6.6.1 InvivoGen Corporation Information
6.6.2 InvivoGen Description and Business Overview
6.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 InvivoGen Herceptin (Trastuzumab) Product Portfolio
6.6.5 InvivoGen Recent Developments/Updates
6.7 Celltrion
6.6.1 Celltrion Corporation Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Celltrion Herceptin (Trastuzumab) Product Portfolio
6.7.5 Celltrion Recent Developments/Updates
6.8 Biocon Limited
6.8.1 Biocon Limited Corporation Information
6.8.2 Biocon Limited Description and Business Overview
6.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Biocon Limited Herceptin (Trastuzumab) Product Portfolio
6.8.5 Biocon Limited Recent Developments/Updates
6.9 Bio-Techne
6.9.1 Bio-Techne Corporation Information
6.9.2 Bio-Techne Description and Business Overview
6.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Bio-Techne Herceptin (Trastuzumab) Product Portfolio
6.9.5 Bio-Techne Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Amgen Herceptin (Trastuzumab) Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 Samsung Bioepis
6.11.1 Samsung Bioepis Corporation Information
6.11.2 Samsung Bioepis Herceptin (Trastuzumab) Description and Business Overview
6.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio
6.11.5 Samsung Bioepis Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Herceptin (Trastuzumab) Description and Business Overview
6.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Merck Herceptin (Trastuzumab) Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Mylan
6.13.1 Mylan Corporation Information
6.13.2 Mylan Herceptin (Trastuzumab) Description and Business Overview
6.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Mylan Herceptin (Trastuzumab) Product Portfolio
6.13.5 Mylan Recent Developments/Updates
6.14 Teva Pharmaceutical
6.14.1 Teva Pharmaceutical Corporation Information
6.14.2 Teva Pharmaceutical Herceptin (Trastuzumab) Description and Business Overview
6.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio
6.14.5 Teva Pharmaceutical Recent Developments/Updates
6.15 Mundipharma
6.15.1 Mundipharma Corporation Information
6.15.2 Mundipharma Herceptin (Trastuzumab) Description and Business Overview
6.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Mundipharma Herceptin (Trastuzumab) Product Portfolio
6.15.5 Mundipharma Recent Developments/Updates
6.16 Mabion
6.16.1 Mabion Corporation Information
6.16.2 Mabion Herceptin (Trastuzumab) Description and Business Overview
6.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Mabion Herceptin (Trastuzumab) Product Portfolio
6.16.5 Mabion Recent Developments/Updates
6.17 AryoGen Biopharma
6.17.1 AryoGen Biopharma Corporation Information
6.17.2 AryoGen Biopharma Herceptin (Trastuzumab) Description and Business Overview
6.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.17.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio
6.17.5 AryoGen Biopharma Recent Developments/Updates
6.18 Genor Biopharma
6.18.1 Genor Biopharma Corporation Information
6.18.2 Genor Biopharma Herceptin (Trastuzumab) Description and Business Overview
6.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Genor Biopharma Herceptin (Trastuzumab) Product Portfolio
6.18.5 Genor Biopharma Recent Developments/Updates
7 Herceptin (Trastuzumab) Manufacturing Cost Analysis
7.1 Herceptin (Trastuzumab) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Herceptin (Trastuzumab)
7.4 Herceptin (Trastuzumab) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Herceptin (Trastuzumab) Distributors List
8.3 Herceptin (Trastuzumab) Customers
9 Herceptin (Trastuzumab) Market Dynamics
9.1 Herceptin (Trastuzumab) Industry Trends
9.2 Herceptin (Trastuzumab) Market Drivers
9.3 Herceptin (Trastuzumab) Market Challenges
9.4 Herceptin (Trastuzumab) Market Restraints
10 Global Market Forecast
10.1 Herceptin (Trastuzumab) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Herceptin (Trastuzumab) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Herceptin (Trastuzumab) by Type (2023-2028)
10.2 Herceptin (Trastuzumab) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Herceptin (Trastuzumab) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Herceptin (Trastuzumab) by Application (2023-2028)
10.3 Herceptin (Trastuzumab) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Herceptin (Trastuzumab) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Herceptin (Trastuzumab) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Herceptin (Trastuzumab) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Herceptin (Trastuzumab) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Herceptin (Trastuzumab) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Herceptin (Trastuzumab) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Herceptin (Trastuzumab) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Herceptin (Trastuzumab) Average Price (K USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Herceptin (Trastuzumab) Manufacturing Sites and Area Served
Table 11. Manufacturers Herceptin (Trastuzumab) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Herceptin (Trastuzumab) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin (Trastuzumab) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Herceptin (Trastuzumab) Sales by Region (2017-2022) & (K Units)
Table 16. Global Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Table 17. Global Herceptin (Trastuzumab) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2017-2022)
Table 19. North America Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 20. North America Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 21. North America Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 23. Europe Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 24. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 25. Europe Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Herceptin (Trastuzumab) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 33. Latin America Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 39. Global Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 40. Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 41. Global Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Herceptin (Trastuzumab) Revenue Share by Type (2017-2022)
Table 43. Global Herceptin (Trastuzumab) Price by Type (2017-2022) & (K USD/Unit)
Table 44. Global Herceptin (Trastuzumab) Sales (K Units) by Application (2017-2022)
Table 45. Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 46. Global Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Herceptin (Trastuzumab) Revenue Share by Application (2017-2022)
Table 48. Global Herceptin (Trastuzumab) Price by Application (2017-2022) & (K USD/Unit)
Table 49. Roche Diagnostics Corporation Information
Table 50. Roche Diagnostics Description and Business Overview
Table 51. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 52. Roche Diagnostics Herceptin (Trastuzumab) Product
Table 53. Roche Diagnostics Recent Developments/Updates
Table 54. Genentech Corporation Information
Table 55. Genentech Description and Business Overview
Table 56. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 57. Genentech Herceptin (Trastuzumab) Product
Table 58. Genentech Recent Developments/Updates
Table 59. Novartis AG Corporation Information
Table 60. Novartis AG Description and Business Overview
Table 61. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 62. Novartis AG Herceptin (Trastuzumab) Product
Table 63. Novartis AG Recent Developments/Updates
Table 64. Pfizer Corporation Information
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 67. Pfizer Herceptin (Trastuzumab) Product
Table 68. Pfizer Recent Developments/Updates
Table 69. Abnova Corporation Corporation Information
Table 70. Abnova Corporation Description and Business Overview
Table 71. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 72. Abnova Corporation Herceptin (Trastuzumab) Product
Table 73. Abnova Corporation Recent Developments/Updates
Table 74. InvivoGen Corporation Information
Table 75. InvivoGen Description and Business Overview
Table 76. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 77. InvivoGen Herceptin (Trastuzumab) Product
Table 78. InvivoGen Recent Developments/Updates
Table 79. Celltrion Corporation Information
Table 80. Celltrion Description and Business Overview
Table 81. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 82. Celltrion Herceptin (Trastuzumab) Product
Table 83. Celltrion Recent Developments/Updates
Table 84. Biocon Limited Corporation Information
Table 85. Biocon Limited Description and Business Overview
Table 86. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 87. Biocon Limited Herceptin (Trastuzumab) Product
Table 88. Biocon Limited Recent Developments/Updates
Table 89. Bio-Techne Corporation Information
Table 90. Bio-Techne Description and Business Overview
Table 91. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 92. Bio-Techne Herceptin (Trastuzumab) Product
Table 93. Bio-Techne Recent Developments/Updates
Table 94. Amgen Corporation Information
Table 95. Amgen Description and Business Overview
Table 96. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 97. Amgen Herceptin (Trastuzumab) Product
Table 98. Amgen Recent Developments/Updates
Table 99. Samsung Bioepis Corporation Information
Table 100. Samsung Bioepis Description and Business Overview
Table 101. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 102. Samsung Bioepis Herceptin (Trastuzumab) Product
Table 103. Samsung Bioepis Recent Developments/Updates
Table 104. Merck Corporation Information
Table 105. Merck Description and Business Overview
Table 106. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 107. Merck Herceptin (Trastuzumab) Product
Table 108. Merck Recent Developments/Updates
Table 109. Mylan Corporation Information
Table 110. Mylan Description and Business Overview
Table 111. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 112. Mylan Herceptin (Trastuzumab) Product
Table 113. Mylan Recent Developments/Updates
Table 114. Teva Pharmaceutical Corporation Information
Table 115. Teva Pharmaceutical Description and Business Overview
Table 116. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 117. Teva Pharmaceutical Herceptin (Trastuzumab) Product
Table 118. Teva Pharmaceutical Recent Developments/Updates
Table 119. Mundipharma Corporation Information
Table 120. Mundipharma Description and Business Overview
Table 121. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 122. Mundipharma Herceptin (Trastuzumab) Product
Table 123. Mundipharma Recent Developments/Updates
Table 124. Mabion Corporation Information
Table 125. Mabion Description and Business Overview
Table 126. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 127. Mabion Herceptin (Trastuzumab) Product
Table 128. Mabion Recent Developments/Updates
Table 129. AryoGen Biopharma Corporation Information
Table 130. AryoGen Biopharma Description and Business Overview
Table 131. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 132. AryoGen Biopharma Herceptin (Trastuzumab) Product
Table 133. AryoGen Biopharma Recent Developments/Updates
Table 134. Genor Biopharma Corporation Information
Table 135. Genor Biopharma Description and Business Overview
Table 136. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 137. Genor Biopharma Herceptin (Trastuzumab) Product
Table 138. Genor Biopharma Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Herceptin (Trastuzumab) Distributors List
Table 142. Herceptin (Trastuzumab) Customers List
Table 143. Herceptin (Trastuzumab) Market Trends
Table 144. Herceptin (Trastuzumab) Market Drivers
Table 145. Herceptin (Trastuzumab) Market Challenges
Table 146. Herceptin (Trastuzumab) Market Restraints
Table 147. Global Herceptin (Trastuzumab) Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Herceptin (Trastuzumab) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Herceptin (Trastuzumab) Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Herceptin (Trastuzumab) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Herceptin (Trastuzumab) Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Herceptin (Trastuzumab) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Herceptin (Trastuzumab)
Figure 2. Global Herceptin (Trastuzumab) Market Share by Type in 2021 & 2028
Figure 3. Breast Cancer Product Picture
Figure 4. Stomach Cancer Product Picture
Figure 5. Others Product Picture
Figure 6. Global Herceptin (Trastuzumab) Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Medical Center
Figure 9. Global Herceptin (Trastuzumab) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Herceptin (Trastuzumab) Market Size (2017-2028) & (US$ Million)
Figure 11. Global Herceptin (Trastuzumab) Sales (2017-2028) & (K Units)
Figure 12. Herceptin (Trastuzumab) Sales Share by Manufacturers in 2021
Figure 13. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Herceptin (Trastuzumab) Players: Market Share by Revenue in 2021
Figure 15. Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Figure 17. Global Herceptin (Trastuzumab) Sales Market Share by Region in 2021
Figure 18. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2017-2022)
Figure 19. Global Herceptin (Trastuzumab) Revenue Market Share by Region in 2021
Figure 20. United States Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Herceptin (Trastuzumab) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Herceptin (Trastuzumab) by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Herceptin (Trastuzumab)
Figure 45. Manufacturing Process Analysis of Herceptin (Trastuzumab)
Figure 46. Herceptin (Trastuzumab) Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics Genentech Novartis AG Pfizer Abnova Corporation InvivoGen Celltrion Biocon Limited Bio-Techne Amgen Samsung Bioepis Merck Mylan Teva Pharmaceutical Mundipharma Mabion AryoGen Biopharma Genor Biopharma